ACE393-103 Vaccination Challenge Study

Status unconfirmed · Phase 2 · Has a placebo group

Conditions studied: Campylobacter Infection

In brief

The purpose of this study is to determine whether ACE393 vaccination can protect against Campylobacteriosis in a challenge model.

Key facts

Study ID

NCT00859716

Run by

TD Vaccines A/S

People needed

72

Starts

2008-10-01

Expected to finish

2009-07-01

Last updated by the study team

2009-03-11

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

Where it is running

• Shin Nippon Biomedical Laboratories — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.